{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:30:21Z","timestamp":1791498621132,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clnesp.2024.06.041","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T18:54:00Z","timestamp":1719600840000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Diagnostic accuracy of a \u2018sarcopenia index\u2019 based on serum biomarkers creatinine and cystatin C in 458,702 UK Biobank participants"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-7752","authenticated-orcid":false,"given":"Thomas J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-3832","authenticated-orcid":false,"given":"Luke A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.06.041_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"101883","key":"10.1016\/j.clnesp.2024.06.041_bib2","article-title":"An elusive consensus definition of sarcopenia impedes research and clinical treatment: a narrative review","volume":"86","author":"Coletta","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clnesp.2024.06.041_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jfa.2017.30","article-title":"Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force","volume":"7","author":"Vellas","year":"2018","journal-title":"J\u00a0Frailty Aging"},{"issue":"3","key":"10.1016\/j.clnesp.2024.06.041_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.22540\/JFSF-04-071","article-title":"Current practice in the diagnosis and management of sarcopenia and frailty\u2013results from a UK-wide survey","volume":"4","author":"Offord","year":"2019","journal-title":"J\u00a0Frailty Sarcopenia Falls"},{"key":"10.1016\/j.clnesp.2024.06.041_bib5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s40520-016-0589-3","article-title":"The role of DXA in sarcopenia","volume":"28","author":"Guglielmi","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.clnesp.2024.06.041_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","article-title":"SARC-F: a simple questionnaire to rapidly diagnose sarcopenia","volume":"14","author":"Malmstrom","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.clnesp.2024.06.041_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000518810","article-title":"Limitations of SARC-F as a screening tool for sarcopenia in patients on hemodialysis","volume":"146","author":"Imamura","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.clnesp.2024.06.041_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00223-022-01054-z","volume":"112","author":"Ladang","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clnesp.2024.06.041_bib9","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clnesp.2024.06.041_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2016.09.007","article-title":"Biomarkers in sarcopenia: a multifactorial approach","volume":"85","author":"Curcio","year":"2016","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1016\/j.clnesp.2024.06.041_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ncn3.11","article-title":"Creatinine\/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis","volume":"1","author":"Tetsuka","year":"2013","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.clnesp.2024.06.041_bib12","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","article-title":"Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients","volume":"8","author":"Thongprayoon","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.clnesp.2024.06.041_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","article-title":"Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature","volume":"4","author":"Patel","year":"2013","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2024.06.041_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnesp.2024.06.041_bib15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1017\/S0007114519002459","article-title":"Sarcopenia and its components in adult renal transplant recipients: prevalence and association with body adiposity","volume":"122","author":"Barreto","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnesp.2024.06.041_bib16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.clnu.2018.05.031","article-title":"Validation of the sarcopenia index to assess muscle mass in the critically ill: a novel application of kidney function markers","volume":"38","author":"Barreto","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.06.041_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12603-020-1495-0","article-title":"Predictive value of serum creatinine\/cystatin C in acute ischemic stroke patients under nutritional intervention","volume":"25","author":"Liu","year":"2021","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.clnesp.2024.06.041_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41598-020-58304-z","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients","volume":"10","author":"Tang","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clnesp.2024.06.041_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13182","article-title":"The sarcopenia index: a novel measure of muscle mass in lung transplant candidates","volume":"32","author":"Kashani","year":"2018","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.clnesp.2024.06.041_bib20","first-page":"323","article-title":"Sarcopenia index in hospitalized patients with chronic obstructive pulmonary disease exacerbation","volume":"81","author":"Warnken-Miralles","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.clnesp.2024.06.041_bib21","first-page":"20200927","article-title":"Sarcopenia index as a predictor of clinical outcomes in older patients with coronary artery disease","volume":"9","author":"Lee","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnesp.2024.06.041_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.clnesp.2024.06.041_bib23","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1038\/s41598-018-29808-6","article-title":"A\u00a0sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people","volume":"8","author":"He","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.06.041_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hlpt.2012.07.003","article-title":"UK Biobank: current status and what it means for epidemiology","volume":"1","author":"Allen","year":"2012","journal-title":"Health Pol Technol"},{"key":"10.1016\/j.clnesp.2024.06.041_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcsm.12705","article-title":"Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study","volume":"12","author":"Wilkinson","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2024.06.041_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcsm.12503","article-title":"Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants","volume":"11","author":"Dodds","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2024.06.041_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clnesp.2024.06.041_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003332","article-title":"Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: a longitudinal cohort study","volume":"17","author":"Chudasama","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnesp.2024.06.041_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12916-019-1339-0","article-title":"Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study","volume":"17","author":"Chudasama","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.clnesp.2024.06.041_bib30","series-title":"Applied logistic regression","first-page":"156","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.clnesp.2024.06.041_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-019-00197-x","article-title":"Serum creatinine and cystatin C-based index can be a screening biomarker for sarcopenia in older population","volume":"10","author":"Singhal","year":"2019","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"10.1016\/j.clnesp.2024.06.041_bib32","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcsm.13006","article-title":"Creatinine-cystatin C ratio and mortality in cancer patients: a retrospective cohort study","volume":"13","author":"Jung","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1122922","key":"10.1016\/j.clnesp.2024.06.041_bib33","first-page":"20230321","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: a retrospective cohort study from the China\u00a0Health and Retirement Longitudinal Study","volume":"11","author":"Wu","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.clnesp.2024.06.041_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/1747-0080.12738","article-title":"The sarcopenia index is an effective predictor for malnutrition in patients with liver cirrhosis","volume":"79","author":"Wu","year":"2022","journal-title":"Nutr Diet"},{"issue":"1","key":"10.1016\/j.clnesp.2024.06.041_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12877-021-02522-1","article-title":"Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Geriatr"},{"issue":"207","key":"10.1016\/j.clnesp.2024.06.041_bib36","first-page":"20220315","article-title":"Serum creatinine\/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clnesp.2024.06.041_bib37","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.clnu.2020.08.010","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease","volume":"40","author":"Hirai","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.06.041_bib38","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"26","key":"10.1016\/j.clnesp.2024.06.041_bib39","first-page":"20220119","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer","volume":"22","author":"Sun","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnesp.2024.06.041_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CIA.S351068","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with mortality, nutritional risk\/malnutrition and sarcopenia in older patients","volume":"17","author":"Ren","year":"2022","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clnesp.2024.06.041_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clnesp.2023.06.002","article-title":"Serum creatinine-to-cystatin C ratio as an indicator of sarcopenia in hemodialysis patients","volume":"56","author":"Yajima","year":"2023","journal-title":"Clin Nutr ESPEN"},{"issue":"963265","key":"10.1016\/j.clnesp.2024.06.041_bib42","first-page":"20220902","article-title":"Serum creatinine\/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours","volume":"9","author":"Ding","year":"2022","journal-title":"Front Nutr"},{"issue":"111032","key":"10.1016\/j.clnesp.2024.06.041_bib43","first-page":"20201012","article-title":"A\u00a0new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer","volume":"82","author":"Fu","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2024.06.041_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:43:24Z","timestamp":1737344604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"alternative-id":["S2405457724001876"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.06.041","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic accuracy of a \u2018sarcopenia index\u2019 based on serum biomarkers creatinine and cystatin C in 458,702 UK Biobank participants","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}